Albert Seymour
2018
In 2018, Albert Seymour earned a total compensation of $2.1M as Chief Scientific Officer at Homology Medicines, a 181% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,760 |
|---|---|
| Option Awards | $1,574,473 |
| Salary | $386,948 |
| Other | $5,576 |
| Total | $2,123,757 |
Seymour received $1.6M in option awards, accounting for 74% of the total pay in 2018.
Seymour also received $156.8K in non-equity incentive plan, $386.9K in salary and $5.6K in other compensation.
Rankings
In 2018, Albert Seymour's compensation ranked 5,410th out of 14,244 executives tracked by ExecPay. In other words, Seymour earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,410 out of 14,244 | 62nd |
Division Manufacturing | 2,043 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 747 out of 2,128 | 65th |
Industry group Drugs | 627 out of 1,817 | 66th |
Industry Pharmaceutical Preparations | 483 out of 1,391 | 65th |
Source: SEC filing on April 25, 2019.
Seymour's colleagues
We found two more compensation records of executives who worked with Albert Seymour at Homology Medicines in 2018.